Marketing-authorisation holder · United States
Rare Disease Therapeutics, Inc. (RDT)
2 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
2 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Anascorp>/=150 ld50 neutralizing units · For Injection | Centruroides immune f injection | United States | Marketed | 2011 |
| AnavipMinimum 780 bothrops asper, 790 c.simus, 244 c.adamanteus, 147 c.atrox, 185 c.scutulatus, 28 agkistrodon contortrix, 61 a.piscivorus ld50 neutralizing units/vial · For Injection | Crotalidae immune f | United States | Marketed | 2015 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 2 | 2 | 0 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.



